Login / Signup

Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML.

Geoffrey L UyLaura F NewellTara L LinStuart L GoldbergMatthew J WieduwiltRobert J RyanStefan FaderlJeffrey E Lancet
Published in: Blood advances (2022)
Keyphrases
  • newly diagnosed
  • acute myeloid leukemia
  • community dwelling
  • middle aged
  • physical activity
  • allogeneic hematopoietic stem cell transplantation